Table 2.

Measuring Outcomes Associated with Patients with Lean vs Non-lean Metabolic dysfunction-associated steatotic liver disease

Outcome	Number of events		Hazard ratio (95% CI)	P value
	Lean	Non-lean
New-onset heart failure, follow-up (yr)
1	2,629	2,159	1.254 (1.184, 1.327)	<0.0001
3	3,335	2,813	1.235 (1.175, 1.299)	<0.0001
5	3,599	3,104	1.219 (1.161, 1.278)	<0.0001
7	3,951	3,411	1.225 (1.17, 1.282)	<0.0001
Composite cardiovascular events, follow-up (yr)
1	1,361	1,120	1.249 (1.154, 1.351)	<0.0001
3	1,936	1,702	1.189 (1.114, 1.269)	<0.0001
5	2,164	1,941	1.179 (1.109, 1.253)	<0.0001
7	2,381	2,158	1.174 (1.107, 1.244)	<0.0001
Composite cerebrovascular events, follow-up (yr)
1	1,403	1,063	1.361 (1.257, 1.474)	<0.0001
3	2,043	1,653	1.297 (1.215, 1.384)	<0.0001
5	2,297	1,906	1.28 (1.204, 1.36)	<0.0001
7	2,521	2,035	1.326 (1.25, 1.405)	<0.0001
All-cause mortality, follow-up (yr)
1	1,233	800	1.588 (1.453, 1.736)	<0.0001
3	1,846	1,239	1.559 (1.451, 1.676)	<0.0001
5	2,109	1,449	1.543 (1.443, 1.649)	<0.0001
7	2,483	1,728	1.538 (1.446, 1.635)	<0.0001